68 citations · 90 across the 4 of their papers we have counts for
Showing stat.APShow all
3 papers · 1 filter
stat.AP2026
Challenges and Opportunities in Statistical Analyses and Designs for Neuroscience Clinical Trials
Jia Jia, Man Jin, Bo Lu +10
Drug development is a complex, costly, and high-risk process, with neuroscience representing one of the most challenging therapeutic areas due to the complexity of neurodegenerativ…
stat.AP2023★ 1 cited
Considerations for Master Protocols Using External Controls
Jie Chen, Xiaoyun, Li +7
There has been an increasing use of master protocols in oncology clinical trials because of its efficiency and flexibility to accelerate cancer drug development. Depending on the s…
stat.AP2020★ 68 cited
Principal Stratum Strategy: Potential Role in Drug Development
Björn Bornkamp, Kaspar Rufibach, Jianchang Lin +6
A randomized trial allows estimation of the causal effect of an intervention compared to a control in the overall population and in subpopulations defined by baseline characteristi…